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Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-system illness characterized,
in part, by increased fatigue following minimal exertion, cognitive impairment, poor recovery to physical and other
stressors, in addition to other symptoms. Unlike healthy subjects and other diseased populations who reproduce
objective physiological measures during repeat cardiopulmonary exercise tests (CPETs), ME/CFS patients have been
reported to fail to reproduce results in a second CPET performed one day after an initial CPET. If confirmed, a
disparity between a first and second CPET could serve to identify individuals with ME/CFS, would be able to
document their extent of disability, and could also provide a physiological basis for prescribing physical activity as
well as a metric of functional impairment.
Methods: 22 subjects diagnosed with ME/CFS completed two repeat CPETs separated by 24 h. Measures of oxygen
consumption (VO2), heart rate (HR), minute ventilation (Ve), workload (Work), and respiratory exchange ratio (RER)
were made at maximal (peak) and ventilatory threshold (VT) intensities. Data were analyzed using ANOVA and
Wilcoxon’s Signed-Rank Test (for RER).
Results: ME/CFS patients showed significant decreases from CPET1 to CPET2 in VO2peak (13.8%), HRpeak (9 bpm),
Ve peak (14.7%), and Work@peak (12.5%). Decreases in VT measures included VO2@VT (15.8%), Ve@VT (7.4%), and
Work@VT (21.3%). Peak RER was high (≥1.1) and did not differ between tests, indicating maximum effort by
participants during both CPETs. If data from only a single CPET test is used, a standard classification of functional
impairment based on VO2peak or VO2@VT results in over-estimation of functional ability for 50% of ME/CFS
participants in this study.
Conclusion: ME/CFS participants were unable to reproduce most physiological measures at both maximal and
ventilatory threshold intensities during a CPET performed 24 hours after a prior maximal exercise test. Our work
confirms that repeated CPETs warrant consideration as a clinical indicator for diagnosing ME/CFS. Furthermore, if
based on only one CPET, functional impairment classification will be mis-identified in many ME/CFS participants.
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Myalgic encephalomyelitis/chronic fatigue syndrome
(ME/CFS) is a multi-system illness that can lead to
striking debilitation. Currently, diagnosis is based on a
symptom profile. A hallmark symptom is referred to as
“post-exertional malaise” (PEM), and encompasses dis-
abling and persistent fatigue following exertion, usually
accompanied by increases in other symptoms, including
cognitive dysfunction [1]. Other common symptoms
include, but are not limited to sleep disturbance, pain,
and symptoms associated with autonomic dysfunction
such as orthostatic intolerance, postural orthostatic tachy-
cardia syndrome (POTS), light and sound sensitivity, and/
or gastrointestinal distress. Fatigue in ME/CFS is not alle-
viated by bed rest and may be exacerbated by physical or
cognitive activity, or other stressors [2]. While both sexes
are afflicted, the incidence of ME/CFS is about 3–4 times
greater in females [3].
Prevalence estimates for ME/CFS vary from 400,000 to
800,000 [3,4] to 1 to 4 million Americans who meet a
case definition criteria for ME/CFS with fewer than 20%
actually diagnosed [5]. Identifying an objective indicator
of ME/CFS would be useful, particularly to accelerate a
normally protracted path to diagnosis. Because post-
exertional fatigue associated with ME/CFS contributes
to physical activity intolerance, a measurement of max-
imal oxygen consumption (VO2peak) would be expected
to indicate low aerobic capacity compared to normal
values for age, sex, and activity level. In fact, measurement
of aerobic capacity or VO2peak in ME/CFS patients is not
standard clinical practice, although VO2peak has been
used to characterize functional capacity in adults [6-13]
and adolescents [14] with ME/CFS. Typically, patients
and/or physicians may not seek assessment using cardio-
pulmonary exercise tests (CPET) to measure VO2peak
until one has been physically inactive or low active for
at least six months or longer. Not surprisingly, reported
VO2peak values of adults with ME/CFS range from 30-
91% of healthy controls or predicted values for age and
sex [7-14] and 86-90% of healthy controls in adolescents
with CFS [14]. While low, these values are generally
consistent with physical deconditioning and are often
not considered to be clinically relevant. In other words,
a low VO2peak from a single CPET reveals low func-
tional capacity, but does not allow the conclusion that
the subject responds abnormally to exercise. However,
ME/CFS patients report that post-exertional fatigue is
not alleviated by rest and sometimes persists for days or
weeks following an exercise challenge [1]. Post-exertional
malaise, or the exacerbation of symptoms following an
increase in a ME/CFS patient’s typical level of activity,
dramatically impacts the ability to carry out both
physical and cognitive activities of daily living. This
major symptom of ME/CFS is included in the mostcommonly used clinical [1,15] and research [16] case
definitions.
As pointed out by Snell et al. [17], the predominant
ME/CFS case definitions fail to operationally define, or
provide guidance to assess responses to exertion. To learn
more about the impact of physical activity on subsequent
physical function, a two-test maximum effort CPET proto-
col has been used to assess the ability of ME/CFS patients
to reproduce VO2peak 24 hours after an initial CPET
[13,17,18]. It is well documented that VO2peak is highly
reliable (test-retest difference ≤ 7%) [19-21] and reprodu-
cible (r ≥ 0.95-0.99) [20,22,23] in healthy active [21] and
inactive adults [19,23], children [24] and many patient
populations [25-30]. Thus, failure of ME/CFS patients to
reproduce VO2peak within the well-established normative
variation of ≤ 7% would indicate an underlying pathophysi-
ology, and could provide a metric of the effects of PEM on
physical activity tolerance and physical function. To date,
studies of physical activity tolerance in ME/CFS using
the two-CPET protocol are few [13,17,18], but indicate
an impaired ability of ME/CFS patients to reproduce
CPET results. For example, studies revealed an inability
of ME/CFS to reproduce VO2peak [13,18], VO2 at venti-
latory threshold [18] or work at peak and/or ventilatory
threshold intensities [17] within normative variation. How-
ever, collectively, these studies have yet to provide consen-
sus on a physiological indicator(s) of impaired metabolic
response to exercise. While these studies reveal obvious
physiological anomalies in the ME/CFS response to exer-
cise stress, limited sample size [13,18] and contrary results
[17] call for additional evidence to more clearly elucidate
the abnormal exercise responses in ME/CFS. More infor-
mation about the response of ME/CFS patients to exercise
will help to further clarify their abnormal physiology and
objectively document functional impairment. Based on
the previous two-day CPET studies, we hypothesized
that ME/CFS would be unable to reproduce normally
physiological indices during a second CPET performed
24 hours following an initial CPET. Therefore, the pur-
pose of this study was to assess the reproducibility of
VO2peak in ME/CFS patients, and secondly, to examine
if a post-exertional measure of VO2peak would change
the classification of functional impairment using a standard
classification scheme.
Methods
Participants
Participants were 22 patients ill with ME/CFS for greater
than 6 months and were diagnosed by referring physicians
based on Fukuda et al. [15]. Each completed a health/
medical history form and cardiovascular screening index
to ascertain health status for inclusion in the study.
Patients were excluded whose cardiovascular status
was determined to be high-risk based on published
Table 1 Physical characteristics and aerobic capacity of
participants, N = 22 (mean ± SD)
Age (y) 43.7 (11.82)
Height (cm) 167.3 (10.19)
Weight (kg) 76.8 (20.28)
BMI (kg.M−2) 27.4 (6.59)
VO2peak - Test 1 (ml
.kg-1.min−1) 21.9 (4.75)
METs@peak (1 MET = 3.5 ml.kg-1.min−1) 6.26 (1.36)
%predVO2peak* - Test 1 77.1% (22.22)
*%predicted VO2peak for sedentary subjects from Bruce et al. [23].
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[31]. Seventeen females (44.8 ± 11.37 yrs) and five males
(39.8 ± 13.92 yrs) were free from co-morbidities or ortho-
pedic limitations that would affect ability to complete a
maximum cycle test. The sample distribution was propor-
tionate with the reported incidence of ME/CFS by sex
(72% females; [3]). The institutional review boards of Ithaca
College and Cornell University approved the study, and
written informed consent was obtained from participants.
Procedures
Participants were instructed to abstain prior to the exer-
cise tests from, 1) consuming food or smoking for 2 h,
2) caffeine or alcohol for 4 h, and 3) exercise for 24 h,
and to use prescribed medications as usual on both test
days. Next, they completed two CPETs (test 1, test 2) on
a cycle ergometer separated by 23–24 hours.
Procedures for CPET began with pre-test resting mea-
sures of 12-lead ECG (Quinton Q4500 ECG, Quinton
Instrument Co., Bothell, WA), blood pressure (BP) and
heart rate (HR) that were made following five minutes of
supine rest. The CPET began with 3 minutes of seated
rest followed by cycling that began at 0 Watt and increased
25 Watts every two minutes until volitional exhaustion, a
request to stop, or termination criteria were met [31]. Pedal
cadence was 60–70 rpm on an electro-magnetically braked
cycle ergometer (Lode Corival, Lode B.V., Groningen-
Holland Medical Technology, Netherlands). Rating of
perceived exertion (RPE; 6–20 scale [32]) was collected
during the last 15 seconds of each workload, BP during
the last minute of each workload, and ECG during each
minute of the test. BP and ECG were monitored during
recovery until the participant was within 20 bpm of pre-
test resting HR and 10 mmHg of resting BP. Cycle seat
height was positioned to approximately 175° of knee ex-
tension, and the same seat height was used for both
tests. Expired gases were collected breath-by-breath
through a two-way breathing valve, and analyzed using
open circuit spirometry. The metabolic measurement
system (PARVO Medics True Max 2400 metabolic
measurement system, Salt Lake City, UT) was calibrated
before each test with ambient air, standard gases of
known concentrations and a 3-L calibration syringe.
Ventilatory threshold (VT) is an analog of anaerobic
threshold, and was identified from expired gases using
the V-Slope [33] algorithm in the metabolic measure-
ment system software. Ventilatory or anaerobic thresh-
old is the exercise intensity at which metabolism
transitions toward increased anaerobic energy produc-
tion. The same trained investigator performed visual as-
sessment and confirmation of the algorithm-derived
VT. Testing took place in a controlled environment
with temperature range of 20-24°C and 15-60% relative
humidity.Statistical analysis
Physiological and work variables at maximum and VT
intensities were compared between CPETs using repeated
measures ANOVA for VO2, heart rate, Work, and minute
ventilation (Ve), as well as for variables derived from these
measures. Maximal respiratory exchange ratio (RERpeak)
was compared between CPETs using a non-parametric
Wilcoxon’s Signed-Rank Test. Statistical significance was
P < 0.05. Analyses were completed with SPSS (version 20,
Armonk, NY:IBM Corp.).
Results
Participant ages ranged from 25 to 57 yrs with a mean of
43.7 ± 11.82 yrs and a body-mass index (BMI) of 27.4 ±
6.59 (Table 1), characterizing this cohort as overweight.
In test 1, participants exhibited an average VO2peak
of 21.9 ml.kg.min−1, which is low, and only 77.1% of
the predicted VO2peak for age/sex-matched sedentary
norms [23]. Physical characteristics and aerobic capacity
of participants in this study were comparable to the 51
female ME/CFS participants studied by Snell et al. [17],
whose age = 46.29 yrs, BMI = 25.96 and VO2peak (test 1) =
21.51 ml.kg.min−1. Likewise, Vermeulen et al. [18] studied
15 female ME/CFS patients who were younger (35.5 yrs)
with normal weight status (BMI = 23.1), but had a similarly
low aerobic capacity (test 1 VO2peak = 22.3 ml
.kg.min−1)
compared to the participants of the present study.
Test-retest changes in physiological and work variables
appear in Table 2 and Figures 1 and 2. We detected sig-
nificant differences in most parameters that were mea-
sured. Significant percent changes from test 1 to test 2
for measures at peak exercise decreased between 8.8 and
16.1%, and measures at ventilatory threshold decreased
between 7.4 and 21.3%. Changes in physiological mea-
sures from test 1 to test 2 for individual subjects appear
in Figures 3 and 4 for peak and ventilatory threshold in-
tensities, respectively.
Participants must achieve valid indicators of maximal
effort to ensure that peak exercise data reflect strong ef-
fort. Maximal effort is indicated by RER ≥1.1 [31]. The
use of RER as a metric of effort during CPET is consist-
ent with the report by the American Heart Association
Table 2 Physiological and work variables for Tests 1 and
2 at peak and ventilatory threshold (VT) intensities,
N = 22 (mean ± SD)
Peak exercise Test 1 Test 2 %diff* P
VO2peak (ml
.kg-1.min−1) 21.9 (4.75) 18.6 (4.06) −13.8% .000¶
%predVO2peak
‡ 77.1% (20.22) 65.2% (15.74) — .000¶
HRpeak (bpm) 159.4 (21.10) 150.0 (23.05) −5.9% .001¶
%predHRpeak† 91.0% (10.75) 85.2% (11.93) — .002¶
Work@peak (W) 122.7 (28.77) 105.7 (33.57) −12.5% .012||
Ve peak (L .min−1) 54.5 (17.56) 44.6 (12.63) −14.7% .003¶
VCO2peak (L
.min−1) 1.91 (.477) 1.58 (.464) −16.1% .000¶
O2 pulse@peak (ml
.beat−1) 10.48 (3.068) 9.46 (2.697) −8.8% .003¶
%predVO2peak
‡ 77.1% (20.22) 65.2% (15.74) — .000¶
RERpeak 1.17 (0.079) 1.14 (0.081) −1.9% .157
Ventilatory threshold
VO2@VT (ml
.kg-1.min−1) 12.2 (3.68) 9.9 (2.89) −15.8% .003¶
HR@VT (bpm) 113.5 (21.78) 107.9 (20.61) −4.9% .086
Work@VT (W) 51.4 (24.97) 41.4 (28.8) −21.3% .030||
Ve@VT (L.min−1) 21.2 (6.07) 18.8 (4.86) −7.4% .035||
VCO2@VT (L
.min−1) 0.86 (.343) 0.72 (.265) −11.3% .014||
O2 pulse@VT (ml
.beat−1) 8.15 (2.603) 7.00 (2.323) −12.6% .003¶
*A negative %diff value indicates a decrease from Test 1 to Test 2.
†Percent of age-predicted maximum heart rate achieved.
‡% predicted VO2peak for sedentary subjects from Bruce et al. [23].
||Statistically significant difference between Test 1 and Test 2 at P < 0.05.
¶Statistically significant difference between Test 1 and Test 2 at P < 0.01.
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curate and reliable indicator of effort. In this cohort, RER
at maximal effort (RERpeak) was high (≥1.1) and did not
differ between tests, indicating that ME/CFS participant
effort was very strong during both CPETs.Figure 1 Changes in physiological and work variables from Test 1 to
maximal respiratory exchange ratio showed that subjects achieved consiste
both tests (P = .157). Statistical significance is shown above bars with **P <All measures at maximal intensity decreased in test 2,
including VO2, HR, Work, minute ventilation and CO2
production (VCO2). One variable, O2 pulse, a surrogate for
cardiac output (O2 pulse@peak) was derived as VO2/HR.
Like both VO2 and HR at peak exercise, O2 pulse also
decreased indicating reduced oxygen delivery in test 2.
Similarly, at ventilatory threshold intensity, all variables,
except HR, decreased during test 2. A decrease in HR@VT
of almost 6 bpm approached but did not achieve statistical
significance (P = 0.086). The larger coefficient of variation
for HR@VT (~19% for tests 1 & 2) compared to HR at
maximal effort (13% for test 1, 15% for test 2) likely con-
tributed to the lack of statistical significance. Collectively,
these data indicate that ME/CFS participants were unable
to reproduce most physiological measures at both max-
imal and ventilatory threshold intensities during test 2,
despite exercising to maximal effort during both tests.
Examination of individual changes from test 1 to test 2 in
Figure 3 reveal that VO2peak decreased in most patients
and did not change in the remaining patients. Patients
whose VO2peak did not change instead demonstrated a
decrease in VO2@VT shown in Figure 4. Thus, all patients
demonstrated clinically significant decreases in either
VO2peak and/or VO2@VT that exceed normative values
for test-retest variability.
Classifying functional impairment, based on VO2peak
or VO2 at ventilatory threshold, could differ for ME/CFS
patients due to a decrease in CPET measures at the time
of the second CPET (Table 3). Using the established
classification system of Weber & Janicki [34], the func-
tional impairment classification based on VO2peak de-
creased in eight participants (37%) due to the change in
VO2peak from test 1 to test 2. When using VO2 at ven-
tilatory threshold to classify functional impairment, the
classification decreased in 12 participants (55%). Overall,Test 2 at maximal intensity. Inset: Non-significant test differences for
ntly high RER (>1.1) for Test 1 and Test 2, with maximum efforts on
0.01 and *P < 0.05.
Figure 2 Changes in physiological and work variables from Test 1 to Test 2 at ventilatory threshold. Statistical significance is shown
above bars with **P < 0.01 and *P < 0.05.
A B
C D
Figure 3 Individual changes in peak measures of VO2 (A), O2pulse (B), work (C) and Ve (D) from Test 1 to Test 2. Subjects’ whose
VO2peak did not decrease during Test 2 showed a decrease in VO2@VT.
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C D
Figure 4 Individual changes in ventilatory threshold measures of VO2 (A), O2pulse (B), work (C) and Ve (D) from Test 1 to Test 2.
Subjects’ whose VO2@VT did not decrease during Test 2 showed a decrease in VO2peak.
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of the ME/CFS cohort due to post-exertional decrements
in VO2peak and/or VO2 at VT. Using only a single CPET,
13 of 22 were classified as “A” (little to no impairment)
and eight were classified as “B” (mild-moderate impair-
ment), which would typically be attributed to physical
deconditioning. Thus the actual functional impairment of
ME/CFS patients is much greater than is measured by a
single CPET.
Discussion
In this study, we sought to clarify the reproducibility of
VO2 at maximal effort (VO2peak) and VO2 at ventilatory
threshold (VO2@VT), an analog for anaerobic threshold, in
patients ill with ME/CFS. Three studies to date [13,17,18]
have demonstrated an abnormal post-exertional response
to exercise in ME/CFS, but they do not agree as to which
physiological measures fail to respond normally in ME/CFS. Second, we wanted to find out how a compromised
test-retest response to exercise would impact a standard
classification of functional impairment based on VO2peak
or VO2@VT. Classification described by Weber and Janicki
[34] was initially devised to categorize functional impair-
ment/exercise intolerance in patients with chronic cardiac
failure, although it is useful for other patient populations in
which impaired gas exchange (oxygen consumption, carbon
dioxide production, minute ventilation) contributes to
exercise intolerance and limits physical function.
The test-retest changes in VO2peak that we observed are
consistent with decrements reported in the three previous
studies of two-day CPET response in ME/CFS [13,17,18],
although the magnitude of decrease in VO2peak varied
among these studies. In the first report to quantify an ab-
normal post-exertional response to exercise in ME/CFS,
VanNess et al. [13] assessed the contribution of VO2peak
measured in six females with ME/CFS and six inactive
Table 3 Change from Test 1 to Test 2 in functional
impairment classification using VO2peak and ventilatory
threshold criteria [34]
VO2peak
(ml.kg-1.min−1)
Number of classes decreased
(# participants)
A (>20) −1 class (N = 5)*
B (16–20) −1 (2) −2 (1)
C (10–15)
D (<10)
Ventilatory threshold
(ml.kg-1.min−1)
A (>14) −1 (2) −2 (2)
B (12–14) −1 (3) −2 (1)
C (9–10) −1 (4)
D (6–7)
Number of participants whose impairment classification decreased on
Test 2 based on criteria of VO2peak, VT, or both VO2peak and VT
VO2peak only VT only VO2peak & VT
4 7 5
*For 5 participants, impairment classification based on Test 1 VO2peak
decreased from “A” to “B” using Test 2 VO2peak.
A – Little-no impairment.
B – Mild-moderate impairment.
C – Moderate-severe impairment.
D – Severe impairment.
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index of maximum effort (e.g., RER) was not reported
with this initial pilot study. Results indicated that a
VO2peak decrement in test 2 alone correctly identified
6 of 6 ME/CFS and 5 of 6 controls, for an overall classi-
fication accuracy of 91.7%. Based on their reported
mean data, VO2peak decreased during test 2 by ~22%
(P = .03), in contrast to a smaller test-retest decrease ob-
served herein of 13.8% (P < 0.001). The more robust
sample size in our study may have contributed to the
smaller decrease in the test-retest measures of VO2peak;
however, for both studies, the test-retest decrement is
considerably greater than <6-7% variability reported
consistently in healthy subjects [19,20,23] and various
patient populations [25-27,29,35-38].
A more recent two-day CPET assessment of ME/CFS by
the same group [17] included 51 females with ME/CFS
and 10 healthy, inactive controls. This study included
measures at ventilatory threshold in a discriminant
function analysis. Similar to their earlier study, CPET
measures distinguished 95.1% of ME/CFS patients from
healthy controls, with a cross-validation accuracy of
90.2%. The primary and secondary discriminating vari-
ables in this study were: 1) work at ventilatory threshold
intensity (decreased ~55%) and 2) work at maximal in-
tensity (decreased ~7%), respectively. In contrast to
their first study [13], VO2peak did not contribute to the
ability to distinguish ME/CFS patients in this cohort.
Further, univariate analysis of VO2peak revealed nosignificant difference between test 1 and test 2 for ME/
CFS, which was within normal variation for VO2peak.
Our results also differ from those of Vermeulen et al.
[18], who measured VO2peak in 15 females with ME/CFS
and 15 healthy female controls who were comparable in
age and BMI. While there was a 2.2% increase (P < 0.05)
in VO2peak controls, they observed a ~6.3% decrease in
VO2peak (P < 0.01) in ME/CFS patients which is compar-
able to normal test-retest variation in healthy subjects. It
is possible that methodological differences between their
study and that of VanNess et al. [13] and our study con-
tributed to the smaller decrease in VO2peak in ME/CFS
patients that they detected. The cycle test protocol used
by Vermeulen et al. [18] was not described in detail and
appeared to vary between subjects. Reproducibility of gas
exchange measures in healthy and other patient popula-
tions relies on consistent testing methodology [22]. Pre-
sumably, the protocol used for the same subject did not
vary between tests, although that was not stated explicitly.
Additionally, authors stated that maximum effort was
assessed using RER, but the RER criterion (ie., RER ≥ 1.1)
was not stated, and RER values were not reported. This is
an important measure to indicate magnitude of effort,
without which it is questionable whether patients gave
maximal effort on both CPETs.
In addition to a 13.8% decrease in VO2peak in ME/CFS
patients, we also observed decreases in maximal work
(12.5%) and maximal heart rate (9 bpm). Likewise, Snell
et al. [17] reported a decrease in maximal work of 7%.
In repeat tests of leg extension strength and endurance,
Paul et al. [39] also demonstrated a delayed recovery in
ME/CFS work output with a greater decrease in quadri-
ceps extension strength and endurance compared to con-
trols following a 24 h repeat test. Conversely, Vermeulen
et al. [18] reported no significant test-retest difference in
maximal heart rate or work in ME/CFS subjects.
We observed a statistically significant test-retest decrease
in maximal O2pulse of 8.8%, indicating compromised
oxygen delivery in ME/CFS patients following induction
of post-exertional malaise. O2pulse, a surrogate measure
for stroke volume and arterio-venous oxygen content
difference (a-vDO2), is a predictor of mortality in patients
with cardiovascular disease [40]. It is an important index
of heart function [41] and may also be associated with the
onset of exercise-induced ischemia [42,43], but is also a
stable and reproducible measure over time in young ath-
letes [44] as well as adult non-athletes [45]. Vermeulen
et al. [18] found a non-significant decrease of ~5% in max-
imal O2pulse in ME/CFS patients [18]. When this group
later measured cardiac output and O2pulse during a single
CPET in 178 ME/CFS patients, lower values were found
in ME/CFS at VT and maximal intensities, but not at rest,
compared to 11 sedentary controls. Additionally, they re-
ported a lower arterio-venous oxygen content difference,
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put, and attributed these findings to lower O2 extraction
by muscles during exercise in ME/CFS [46]. While it is
not known how alteration in oxygen delivery/utilization
occurs during a subsequent CPET in ME/CFS patients,
these results and others [47] also suggest that the decrease
in maximal O2pulse may partly explain the concomitant
reduction in maximal workload in ME/CFS that we
observed.
Our data showed a substantial decrease of 15.8% in
test-retest VO2 at VT. Large decreases in VO2 at VT
were also reported by VanNess et al. [13] (~27%) and
Snell et al. [17] (~11%). Although the test-retest decrease
(7%) reported by Vermeulen et al. [18] was not statisti-
cally significant, there was a significant group by test
interaction (P < 0.05) due to an increase in control sub-
jects. In contrast, gas exchange variables and work at
VT are reliable and reproducible in healthy subjects and
athletes [21,48], including test-retest differences of 1.5%
for VO2 (r = .82-.97, Standard Error of Measurement
(SEm) = 2.64 ml
.kg.min−1), and 1.5% for cycle work
(SEm = 4.5 W) or treadmill velocity (SEm = 10 m
.min−1)
(r = .95-.99). Oxygen consumption at VT in cardiac pa-
tients (Weber class A, B, C) is also stable and reprodu-
cible in multiple measures over months, albeit with
somewhat more variability (CV = 9.2%) compared to
healthy subjects [38].
Work measured at VT decreased 21.3% in our sub-
jects as well as a remarkable 55% reported by Snell et al.
[17]. VanNess et al. [13] did not report work at VT, and
Vermeulen et al. [18] found no significant difference in
the univariate comparison of test-retest work at VT, but
did find a significant group by test interaction (P < 0.05).
O2 pulse at VT decreased significantly in our subjects
(12.6%) and in Vermeulen et al. [18] (9%) and was not
reported by VanNess et al. [13] or Snell et al. [17].
Changes in physiological measures indicate a substantial
post-exertional decrement in performance at ventilatory
threshold in ME/CFS 24 hours after an initial CPET. Ven-
tilatory or anaerobic threshold intensity indicates the
workload, heart rate and/or oxygen consumption at which
anaerobic metabolism begins to predominate. Thus, after
induction of post-exertional malaise, the threshold lowers
at which anaerobic metabolism accelerates in ME/CFS.
This causes premature anaerobiosis in ME/CFS patients
after they have endured an earlier physical challenge,
further reducing the ability to do work. It is therefore
not surprising that Snell et al. [17] found that work at
ventilatory threshold contributed most substantially to
differentiate ME/CFS from healthy controls.
Use of a single CPET only to indicate functional im-
pairment in ME/CFS is problematic. The results of this
study, and the consensus of the three previous studies of
test-retest CPETs in ME-CFS patients, provide strongevidence of impaired physiological responses to exercise.
More specifically, the abnormal post-exertional responses
to exercise in ME/CFS are marked by test-retest decreases
in VO2 and work at both maximum and ventilatory
threshold intensities. Data from a single CPET resulted in
classification of 12 of 22 patients as having little or no im-
pairment, and eight as having mild/moderate impairment.
Such individuals would likely be prescribed graded exer-
cise therapy (GET) to improve aerobic capacity. However,
data from the second CPET in this and prior studies
[13,17,18] indicate that aerobic energy-producing pro-
cesses fail to respond normally to exercise stress in
ME/CFS patients. Thus, incautiously applied GET is likely
to result in exacerbation of fatigue and other symptoms of
ME/CFS patients.
Little is understood about the anomalous post-exertional
response to exercise in ME/CFS. We know that our data
does not result from any methodological or equipment
problems, because during the same time period the ME/
CFS patients were being tested, we performed several re-
peat CPETs on healthy individuals, who demonstrated
comparable or better consistency and reproducibility for
VO2peak compared to published values [19-21,23,48]. The
consistently high RER values during CPET 2 provide
sound evidence that ME/CFS patients can, in fact, work to
maximal effort in a repeat CPET. Values for maximal RER
of 1.17 and 1.14 that were reported in this study would
be taken as an indication of strong, maximal efforts if
reported in healthy subjects and athletes [49,50]. ME/
CFS patients currently represent a unique class of ill pa-
tients who do not reproduce maximal CPET measures,
unlike individuals with cardiovascular disease [27,30]
lung disease [28], end-stage renal disease [26], pulmon-
ary arterial hypertension [25] and cystic fibrosis [29].
A limitation of this study should be addressed in follow-
up research. Together with the three previous studies of
the two-day CPET protocol [13,17,18], the collective re-
sults demonstrate consistently abnormal CPET results in
ME/CFS during test 2. However, the variation in abnormal
CPET responses among these studies was not clarified in
the present study and requires a larger sample size with
robust statistical power.
Subsequent research should strive to address the fol-
lowing questions regarding post-exertional fatigue in
ME/CFS. Inclusion of additional males in subsequent
research should allow us to ascertain whether there are
sex differences in response to the two-day CPET proto-
col. A large sample size will be needed to determine
whether we can sub-classify ME/CFS patients based on
differential responses to the two-day CPET protocol at
maximal and ventilatory threshold intensities. With
additional participants, it would be possible to identify
clinically relevant exercise measurement cutpoints and
odds ratios for use by practitioners in the diagnosis and
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to and following the two-day CPET should be quantified
to correlate changes with the decrement measured during
testing.
Conclusions
The results of this study confirm previous work [13,17,18]
that demonstrated an abnormal response to exercise in
fatigued ME/CFS patients. The use of a two-day CPET
protocol to measure the post-exertional response to ex-
ercise in ME/CFS allows us to better study the nature of
this unusual, debilitating type of symptom exacerbation
that follows exertion or stress, often described as post-
exertional malaise or neuro-immune fatigue. Addition-
ally, this test protocol yields information that can pro-
vide specific guidelines for exertion in ME/CFS patients
in order to avoid symptom flares and that may improve
daily physical function. ME/CFS patients exhibited sig-
nificant post-exertional declines in VO2, work, minute
ventilation and O2 pulse at both maximal and ventila-
tory threshold intensities. Consequently, classification
of functional impairment based on VO2peak and VO2 at
ventilatory threshold over-estimated the functional ability
of 50% of ME/CFS in this sample when based on only
one CPET.
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